组委会 Xuetao Cao, Chinese Academy of Medical Sciences, China Olivera J. Finn, University of Pittsburgh, USA Shimon Sakaguchi, Osaka University, Japan Laurence Zitvogel, INSERM, France 会议主题 1. Defining tumor antigens and immunogenicity 2. Vaccine-based immunotherapy 3. Immune checkpoint blockade 4. Antibody therapy 5. Adoptive T cell therapy 6. Gut microbiota, immunity and cancer 7. Inflammation, tumor microenvironment and immune escape 8. New approach to cancer immunotherapy 特邀嘉宾 Lieping Chen, Yale University School of Medicine, USA 邀请嘉宾 Nina Bhardwaj, Icahn School of Medicine at Mt Sinai, Tisch Cancer Institute, USA Xuetao Cao, Chinese Academy of Medical Sciences/The Second Military Medical University, CHINA Madhav Dhodapkar, Yale University, USA Olivera Finn, University of Pittsburgh School of Medicine, USA Holbrook Kohrt, Stanford School of Medicine, USA Ming Li, Memorial Sloan-Kettering Cancer Center, USA Ofer Mandelboim, The Hebrew University of Jerusalem, ISRAEL Michael Platten, University of Heidelberg Medical Center, GERMANY Zhihai Qin, Institute of Biophysics, CAS, China Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA Shimon Sakaguchi, Osaka University, JAPAN Tadatsugu Taniguchi, University of Tokyo Institute of Industrial Science, JAPAN Kris Thielemans, Vrije Universiteit Brussel, BELGIUM Rongfu Wang, Houston Methodist Research Institute, USA Laurence Zitvogel, Institut Gustave Roussy(IGR), FRANCE Weiping Zou, University of Michigan Medical School, USA Tel: +86-512-62729029; Email: meetings@csh-asia.org Address: No. 299, Qiyue Road, Suzhou, China www.csh-asia.org